Some combined Alzheimer's therapies improved cognitive test scores in a review
A network meta-analysis reported better scores for specific combinations, but the abstract does not quantify their effects or provide confidence ratings.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Compared with placebo or usual care, donepezil with cognitive therapy and rivastigmine with cognitive rehabilitation improved Mini-Mental State Examination scores. The review also reported behavioral and functional improvements with some approaches. Without effect sizes, uncertainty estimates or reported confidence ratings, the abstract cannot show how large these gains were or establish a dependable treatment hierarchy.
The results and conclusion disagree about the highest-ranked behavioral approach. Follow-up lengths, effect sizes and confidence judgments are not reported, limiting this abstract-based comparison and preventing firm conclusions about treatment superiority.
Understanding treatment rankings
The review compared treatments through a network meta-analysis and ranked them separately for cognition, behavior and function. A high ranking is not a percentage improvement in health, and rankings alone do not describe benefit size.
Keeping outcomes separate
The results also describe gains in functional status with rivastigmine plus cognitive stimulation, and with exercise. These findings concern a different outcome from cognitive test performance and do not establish improvement across every aspect of Alzheimer's disease.
The original publication
Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis.
Boongird C, Anothaisintawee T, Tearneukit W et al.
J Alzheimers Dis · 2025
- PubMed ID
- 41042837
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.